ID   CP4FB_HUMAN             Reviewed;         524 AA.
AC   Q9HBI6; A0A024R7G0; A8K059; O75254; Q96AQ5;
DT   10-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   10-MAY-2017, entry version 150.
DE   RecName: Full=Phylloquinone omega-hydroxylase CYP4F11 {ECO:0000305};
DE            EC=1.14.13.194 {ECO:0000269|PubMed:24138531};
DE   AltName: Full=3-hydroxy fatty acids omega-hydroxylase CYP4F11 {ECO:0000305};
DE            EC=1.14.13.- {ECO:0000305};
DE   AltName: Full=Cytochrome P450 4F11;
DE            Short=CYPIVF11;
GN   Name=CYP4F11 {ECO:0000312|HGNC:HGNC:13265};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND VARIANTS ARG-276
RP   AND ASN-446.
RC   TISSUE=Brain, and Liver;
RX   PubMed=10964514; DOI=10.1006/geno.2000.6276;
RA   Cui X., Nelson D.R., Strobel H.W.;
RT   "A novel human cytochrome P450 4F isoform (CYP4F11): cDNA cloning,
RT   expression, and genomic structural characterization.";
RL   Genomics 68:161-166(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS ARG-276 AND
RP   ASN-446.
RC   TISSUE=Mammary gland {ECO:0000312|EMBL:BAF82113.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ARG-276.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS ARG-276 AND
RP   ASN-446.
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=15364545; DOI=10.1016/j.taap.2003.12.033;
RA   Kalsotra A., Turman C.M., Kikuta Y., Strobel H.W.;
RT   "Expression and characterization of human cytochrome P450 4F11:
RT   Putative role in the metabolism of therapeutic drugs and
RT   eicosanoids.";
RL   Toxicol. Appl. Pharmacol. 199:295-304(2004).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=18065749; DOI=10.1194/jlr.M700450-JLR200;
RA   Dhar M., Sepkovic D.W., Hirani V., Magnusson R.P., Lasker J.M.;
RT   "Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene
RT   subfamily enzyme CYP4F11.";
RL   J. Lipid Res. 49:612-624(2008).
RN   [8]
RP   FUNCTION.
RX   PubMed=19932081; DOI=10.1016/j.abb.2009.11.017;
RA   Tang Z., Salamanca-Pinzon S.G., Wu Z.L., Xiao Y., Guengerich F.P.;
RT   "Human cytochrome P450 4F11: heterologous expression in bacteria,
RT   purification, and characterization of catalytic function.";
RL   Arch. Biochem. Biophys. 494:86-93(2010).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES,
RP   IDENTIFICATION BY MASS SPECTROMETRY, PATHWAY, AND CHARACTERIZATION OF
RP   VARIANT ASN-446.
RX   PubMed=24138531; DOI=10.1021/bi401208m;
RA   Edson K.Z., Prasad B., Unadkat J.D., Suhara Y., Okano T.,
RA   Guengerich F.P., Rettie A.E.;
RT   "Cytochrome P450-dependent catabolism of vitamin K: omega-
RT   hydroxylation catalyzed by human CYP4F2 and CYP4F11.";
RL   Biochemistry 52:8276-8285(2013).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Omega-hydroxylase that oxidizes a variety of
CC       structurally unrelated compounds, including fatty acids and
CC       xenobiotics. Plays a key role in vitamin K catabolism by mediating
CC       omega-hydroxylation of vitamin K1 (phylloquinone), and
CC       menaquinone-4 (MK-4), a form of vitamin K2. Hydroxylation of
CC       phylloquinone and MK-4 probably regulates blood coagulation
CC       (PubMed:24138531). Catalyzes omega-hydroxylation of 3-hydroxy
CC       fatty acids, such as 3-hydroxypalmitate, 3-hydroxyoleate, 3-
CC       hydroxyarachidonate, and 3-hydroxystearate (PubMed:18065749,
CC       PubMed:19932081). Oxidizes drugs such as erythromycin,
CC       benzphetamine, ethylmorphine, chlorpromazine and imipramine
CC       (PubMed:15364545). {ECO:0000269|PubMed:15364545,
CC       ECO:0000269|PubMed:18065749, ECO:0000269|PubMed:19932081,
CC       ECO:0000269|PubMed:24138531}.
CC   -!- CATALYTIC ACTIVITY: Phylloquinone + NADPH + O(2) = omega-
CC       hydroxyphylloquinone + NADP(+) + H(2)O.
CC       {ECO:0000269|PubMed:24138531}.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC         Evidence={ECO:0000250|UniProtKB:P24464};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=53.5 mM for 3-hydroxystearate {ECO:0000269|PubMed:18065749};
CC         KM=105.8 mM for 3-hydroxypalmitate
CC         {ECO:0000269|PubMed:18065749};
CC         KM=2.4 uM for menaquinone-4 (MK-4)
CC         {ECO:0000269|PubMed:24138531};
CC         KM=125 uM for erythromycin {ECO:0000269|PubMed:15364545};
CC         Vmax=830 pmol/min/ng enzyme with erythromycin as substrate
CC         {ECO:0000269|PubMed:15364545};
CC         Note=kcat is 0.088 min(-1) with menaquinone-4 (MK-4) as
CC         substrate. {ECO:0000269|PubMed:24138531};
CC   -!- PATHWAY: Cofactor degradation; phylloquinone degradation.
CC       {ECO:0000269|PubMed:24138531}.
CC   -!- SUBCELLULAR LOCATION: Microsome membrane
CC       {ECO:0000269|PubMed:18065749}; Single-pass membrane protein
CC       {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed mainly in human liver, followed by
CC       kidney, heart, and skeletal muscle. {ECO:0000269|PubMed:10964514,
CC       ECO:0000269|PubMed:24138531}.
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC27731.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF236085; AAG15889.1; -; mRNA.
DR   EMBL; AK289424; BAF82113.1; -; mRNA.
DR   EMBL; AC005336; AAC27731.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AC020950; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011517; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471106; EAW84512.1; -; Genomic_DNA.
DR   EMBL; CH471106; EAW84513.1; -; Genomic_DNA.
DR   EMBL; BC016853; AAH16853.1; -; mRNA.
DR   CCDS; CCDS12337.1; -.
DR   RefSeq; NP_001122404.1; NM_001128932.1.
DR   RefSeq; NP_067010.3; NM_021187.3.
DR   UniGene; Hs.187393; -.
DR   ProteinModelPortal; Q9HBI6; -.
DR   SMR; Q9HBI6; -.
DR   BioGrid; 121790; 1.
DR   IntAct; Q9HBI6; 1.
DR   STRING; 9606.ENSP00000248041; -.
DR   SwissLipids; SLP:000000470; -.
DR   iPTMnet; Q9HBI6; -.
DR   PhosphoSitePlus; Q9HBI6; -.
DR   BioMuta; CYP4F11; -.
DR   DMDM; 296439388; -.
DR   MaxQB; Q9HBI6; -.
DR   PaxDb; Q9HBI6; -.
DR   PeptideAtlas; Q9HBI6; -.
DR   PRIDE; Q9HBI6; -.
DR   DNASU; 57834; -.
DR   Ensembl; ENST00000248041; ENSP00000248041; ENSG00000171903.
DR   Ensembl; ENST00000402119; ENSP00000384588; ENSG00000171903.
DR   GeneID; 57834; -.
DR   KEGG; hsa:57834; -.
DR   UCSC; uc002nbt.3; human.
DR   CTD; 57834; -.
DR   DisGeNET; 57834; -.
DR   GeneCards; CYP4F11; -.
DR   H-InvDB; HIX0014857; -.
DR   HGNC; HGNC:13265; CYP4F11.
DR   HPA; CAB033648; -.
DR   HPA; HPA017265; -.
DR   HPA; HPA058960; -.
DR   MIM; 611517; gene.
DR   neXtProt; NX_Q9HBI6; -.
DR   OpenTargets; ENSG00000171903; -.
DR   PharmGKB; PA27120; -.
DR   eggNOG; KOG0157; Eukaryota.
DR   eggNOG; COG2124; LUCA.
DR   GeneTree; ENSGT00760000118816; -.
DR   HOGENOM; HOG000233833; -.
DR   HOVERGEN; HBG000182; -.
DR   InParanoid; Q9HBI6; -.
DR   KO; K17729; -.
DR   OMA; FRILPTH; -.
DR   OrthoDB; EOG091G06KN; -.
DR   PhylomeDB; Q9HBI6; -.
DR   TreeFam; TF105088; -.
DR   Reactome; R-HSA-211935; Fatty acids.
DR   Reactome; R-HSA-211958; Miscellaneous substrates.
DR   Reactome; R-HSA-211979; Eicosanoids.
DR   Reactome; R-HSA-2142691; Synthesis of Leukotrienes (LT) and Eoxins (EX).
DR   UniPathway; UPA01054; -.
DR   GeneWiki; CYP4F11; -.
DR   GenomeRNAi; 57834; -.
DR   PRO; PR:Q9HBI6; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000171903; -.
DR   CleanEx; HS_CYP4F11; -.
DR   ExpressionAtlas; Q9HBI6; baseline and differential.
DR   Genevisible; Q9HBI6; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031090; C:organelle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0020037; F:heme binding; TAS:UniProtKB.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0004497; F:monooxygenase activity; TAS:Reactome.
DR   GO; GO:0016709; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; IDA:UniProtKB.
DR   GO; GO:0007596; P:blood coagulation; TAS:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; TAS:UniProtKB.
DR   GO; GO:0042361; P:menaquinone catabolic process; IDA:UniProtKB.
DR   GO; GO:0055114; P:oxidation-reduction process; TAS:UniProtKB.
DR   GO; GO:0042376; P:phylloquinone catabolic process; IDA:UniProtKB.
DR   GO; GO:0042377; P:vitamin K catabolic process; IDA:UniProtKB.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR002401; Cyt_P450_E_grp-I.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00463; EP450I.
DR   PRINTS; PR00385; P450.
DR   SUPFAM; SSF48264; SSF48264; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Endoplasmic reticulum; Heme; Iron; Membrane;
KW   Metal-binding; Microsome; Monooxygenase; NADP; Oxidoreductase;
KW   Polymorphism; Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1    524       Phylloquinone omega-hydroxylase CYP4F11.
FT                                /FTId=PRO_0000051856.
FT   TRANSMEM     15     37       Helical. {ECO:0000255}.
FT   METAL       468    468       Iron (heme axial ligand).
FT                                {ECO:0000250|UniProtKB:P24464}.
FT   BINDING     328    328       Heme (covalent; via 1 link).
FT                                {ECO:0000250|UniProtKB:P24464}.
FT   VARIANT     146    146       R -> C (in dbSNP:rs57519667).
FT                                /FTId=VAR_060265.
FT   VARIANT     276    276       C -> R (in dbSNP:rs8104361).
FT                                {ECO:0000269|PubMed:10964514,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_060266.
FT   VARIANT     446    446       D -> N (common polymorphism; does not
FT                                affect enzyme activity; dbSNP:rs1060463).
FT                                {ECO:0000269|PubMed:10964514,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:24138531}.
FT                                /FTId=VAR_071198.
FT   CONFLICT    458    458       F -> L (in Ref. 2; BAF82113).
FT                                {ECO:0000305}.
FT   CONFLICT    496    496       T -> I (in Ref. 1; AAG15889).
FT                                {ECO:0000305}.
SQ   SEQUENCE   524 AA;  60146 MW;  8B0F14C52E657CB2 CRC64;
     MPQLSLSWLG LGPVAASPWL LLLLVGGSWL LARVLAWTYT FYDNCRRLQC FPQPPKQNWF
     WGHQGLVTPT EEGMKTLTQL VTTYPQGFKL WLGPTFPLLI LCHPDIIRPI TSASAAVAPK
     DMIFYGFLKP WLGDGLLLSG GDKWSRHRRM LTPAFHFNIL KPYMKIFNKS VNIMHDKWQR
     LASEGSARLD MFEHISLMTL DSLQKCVFSF ESNCQEKPSE YIAAILELSA FVEKRNQQIL
     LHTDFLYYLT PDGQRFRRAC HLVHDFTDAV IQERRCTLPT QGIDDFLKNK AKSKTLDFID
     VLLLSKDEDG KELSDEDIRA EADTFMFEGH DTTASGLSWV LYHLAKHPEY QEQCRQEVQE
     LLKDREPIEI EWDDLAQLPF LTMCIKESLR LHPPVPVISR CCTQDFVLPD GRVIPKGIVC
     LINIIGIHYN PTVWPDPEVY DPFRFDQENI KERSPLAFIP FSAGPRNCIG QAFAMAEMKV
     VLALTLLHFR ILPTHTEPRR KPELILRAEG GLWLRVEPLG ANSQ
//
